Tag: biotech partnerships
Boehringer bets up to $1B on RNA splicing targets from Envisagenics
The New York company will mine alternative splicing for tumor-specific targets that drug makers can turn into therapies.
The New York company will mine alternative splicing for tumor-specific targets that drug makers can turn into therapies.